OSTX – os therapies incorporated (US:NASDAQ)
Stock Stats
News
OS Therapies Announces Positive Data for OST-HER2 in the Treatment of Unresected Osteosarcoma in Dogs Opening the Potential for Use as Front-Line Therapy in Humans [Yahoo! Finance]
OS Therapies Announces Positive Data for OST-HER2 in the Treatment of Unresected Osteosarcoma in Dogs Opening the Potential for Use as Front-Line Therapy in Humans
OS Therapies Completes Acquisition of Advaxis Immunotherapies Clinical, Pre-clinical and IP Assets from Ayala Pharmaceuticals [Yahoo! Finance]
OS Therapies Completes Acquisition of Advaxis Immunotherapies Clinical, Pre-clinical and IP Assets from Ayala Pharmaceuticals
OS Therapies Inc (NYSE: OSTX) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $20.00 price target on the stock.
Form 8-K OS Therapies Inc For: Apr 09
Form 8-K OS Therapies Inc For: Mar 31
Form DEFA14A OS Therapies Inc
Form 8-K OS Therapies Inc For: Mar 31
Form 10-K OS Therapies Inc For: Dec 31
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.